56703-36-7

Upstream product

• 64-17-5 ethanol 
• 37142-39-5 4-(2-bromoethoxy)benzonitrile 
• 1027062-64-1 4-(2-Methanesulfonyloxy-ethoxy)-benzoic acid ethyl ester 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 30893-58-4 4-(ethoxycarbonyl)phenoxyacetic acid 
• 25389-23-5 ethyl 4-(2-hydroxyethoxy)benzoate 
• 29936-92-3 ethyl 4-(ethoxycarbonyl)phenoxyacetate 

Downstream Products

• 97988-30-2 1-<2-<4-(ethoxycarbonyl)phenoxy>ethyl>-1H-1,2,4-triazole 
• 170799-65-2 ethyl 4-<2-(2-cyano-3-methoxy-2-cyclopentenyl)ethoxy>benzoate 
• 149325-67-7 4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoic acid 
• 170799-60-7 ethyl 4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoate 
• 170799-52-7 diethyl N-<4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoyl>-L-glutamate 
• 119932-48-8 sodium 4-<2-(1H-triazol-1-yl)ethoxy>benzoate 

Relevant academic research and scientific papers

Novel 6-5 fused ring heterocycle antifolates with potent antitumor activity: Bridge modifications and heterocyclic benzoyl isosters of 2,4-diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine antifolate

Structural modifications of an extremely potent inhibitor of dihydrofolate reductase (DHFR) activity and tumor cell growth, N-[4-[3-(2,4-diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidin-5-yl)propyl ]benzoyl]-L-glutamic acid (1), have led to the synthesis of

Cyclopentane derivatives manufacture

The present invention relates to new cyclopentane derivatives having the formula STR1 and to a process for their manufacture. The compounds can be used as medicaments due to their antiprostaglandin effect.

Novel cyclopentane derivatives

The present invention relates to novel not naturally occurring 10,11-dihydro-derivatives of prostaglandins of the A-series as well as a process for their preparation. The compounds of the invention have an antiprostaglandin effect and may be used as medicaments for the inhibition or suppression pharmacological properties of the prostaglandins.